These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 11560062
1. Structure-based virtual screening protocols. Good A. Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062 [Abstract] [Full Text] [Related]
4. Analysis and optimization of structure-based virtual screening protocols. (3). New methods and old problems in scoring function design. Smith R, Hubbard RE, Gschwend DA, Leach AR, Good AC. J Mol Graph Model; 2003 Sep; 22(1):41-53. PubMed ID: 12798390 [Abstract] [Full Text] [Related]
7. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site. Virtanen SI, Pentikäinen OT. J Chem Inf Model; 2010 Jun 28; 50(6):1005-11. PubMed ID: 20504004 [Abstract] [Full Text] [Related]
9. Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success. Good AC, Cheney DL, Sitkoff DF, Tokarski JS, Stouch TR, Bassolino DA, Krystek SR, Li Y, Mason JS, Perkins TD. J Mol Graph Model; 2003 Sep 28; 22(1):31-40. PubMed ID: 12798389 [Abstract] [Full Text] [Related]
10. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems. Kellenberger E, Foata N, Rognan D. J Chem Inf Model; 2008 May 28; 48(5):1014-25. PubMed ID: 18412328 [Abstract] [Full Text] [Related]
11. Ligand-target interaction-based weighting of substructures for virtual screening. Crisman TJ, Sisay MT, Bajorath J. J Chem Inf Model; 2008 Oct 28; 48(10):1955-64. PubMed ID: 18821751 [Abstract] [Full Text] [Related]
12. Beyond the virtual screening paradigm: structure-based searching for new lead compounds. Schlosser J, Rarey M. J Chem Inf Model; 2009 Apr 28; 49(4):800-9. PubMed ID: 19354328 [Abstract] [Full Text] [Related]
15. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Tanrikulu Y, Schneider G. Nat Rev Drug Discov; 2008 Aug 28; 7(8):667-77. PubMed ID: 18636071 [Abstract] [Full Text] [Related]
16. Virtual screening strategies in drug discovery. McInnes C. Curr Opin Chem Biol; 2007 Oct 28; 11(5):494-502. PubMed ID: 17936059 [Abstract] [Full Text] [Related]
17. Virtual screening in lead discovery and optimization. Jain AN. Curr Opin Drug Discov Devel; 2004 Jul 28; 7(4):396-403. PubMed ID: 15338948 [Abstract] [Full Text] [Related]
18. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors. Mizutani MY, Itai A. J Med Chem; 2004 Sep 23; 47(20):4818-28. PubMed ID: 15369385 [Abstract] [Full Text] [Related]
19. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening. Pérez-Nueno VI, Pettersson S, Ritchie DW, Borrell JI, Teixidó J. J Chem Inf Model; 2009 Apr 23; 49(4):810-23. PubMed ID: 19358515 [Abstract] [Full Text] [Related]
20. Virtual high-throughput screening of molecular databases. Seifert MH, Kraus J, Kramer B. Curr Opin Drug Discov Devel; 2007 May 23; 10(3):298-307. PubMed ID: 17554856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]